Registry of Celution Device for Processing ADRCs and Healing in Muscle and Ligament Sports Injuries

NCT02770755 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-05-12

No results posted yet for this study

Summary

This registry study will compile information about patients who are scheduled to receive or have received Adipose Derived Regenerative cells (ADRCs) prepared by Celution device to treat muscle and ligament sports injuries.

Conditions

  • Muscle Tear

Sponsors & Collaborators

  • Cytori Therapeutics

    lead INDUSTRY

Principal Investigators

  • Steven Kesten, M.D. · Cytori Therapeutics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-06-30
Completion
2017-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02770755 on ClinicalTrials.gov